
Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in …

Regeneron has revealed that REGN-COV2, its two-antibody vaccine for the treatment and prevention of COVID-19, has been awarded a manufacturing …

The Trump administration has selected the finalists for the COVID-19 vaccine it is seeking to make widely available by the …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

